ProQR Therapeutics NV (PRQR)
1.625
-0.02
(-1.52%)
USD |
NASDAQ |
Oct 07, 12:25
ProQR Therapeutics Price to Book Value : 2.524 for Oct. 7, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 2.563 |
| October 05, 2026 | 2.594 |
| October 02, 2026 | 2.539 |
| October 01, 2026 | 2.532 |
| September 30, 2026 | 2.578 |
| September 29, 2026 | 2.563 |
| September 28, 2026 | 2.563 |
| September 25, 2026 | 2.563 |
| September 24, 2026 | 2.656 |
| September 23, 2026 | 2.640 |
| September 22, 2026 | 2.951 |
| September 21, 2026 | 2.889 |
| September 18, 2026 | 2.842 |
| September 17, 2026 | 2.935 |
| September 16, 2026 | 2.889 |
| September 15, 2026 | 2.858 |
| September 14, 2026 | 2.889 |
| September 11, 2026 | 2.889 |
| September 10, 2026 | 3.013 |
| September 09, 2026 | 3.091 |
| September 08, 2026 | 3.184 |
| September 04, 2026 | 3.215 |
| September 03, 2026 | 3.246 |
| September 02, 2026 | 3.339 |
| September 01, 2026 | 3.292 |
| Date | Value |
|---|---|
| August 31, 2026 | 3.308 |
| August 28, 2026 | 3.556 |
| August 27, 2026 | 3.603 |
| August 26, 2026 | 3.650 |
| August 25, 2026 | 3.696 |
| August 24, 2026 | 3.774 |
| August 21, 2026 | 3.634 |
| August 20, 2026 | 3.525 |
| August 19, 2026 | 3.448 |
| August 18, 2026 | 3.339 |
| August 17, 2026 | 2.997 |
| August 14, 2026 | 2.982 |
| August 13, 2026 | 2.873 |
| August 12, 2026 | 2.889 |
| August 11, 2026 | 2.982 |
| August 10, 2026 | 2.811 |
| August 07, 2026 | 2.912 |
| August 06, 2026 | 2.951 |
| August 05, 2026 | 3.060 |
| August 04, 2026 | 2.842 |
| August 03, 2026 | 2.656 |
| July 31, 2026 | 2.671 |
| July 30, 2026 | 2.764 |
| July 29, 2026 | 2.687 |
| July 28, 2026 | 2.733 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Pharming Group NV | 2.666 |
| NewAmsterdam Pharma Co. NV | 4.230 |
| argenx SE | -- |
| Mirum Pharmaceuticals, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 2.591 |
Price to Book Value Related Metrics
| PS Ratio | 8.048 |
| PEG Ratio | -0.7654 |
| Price | 1.625 |
| Earnings Yield | -28.54% |
| Market Cap | 229.32M |
| PEGY Ratio | -0.7654 |